These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9564739)

  • 21. One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.
    Parrinello G; Paterna S; Torres D; Di Pasquale P; Mezzero M; La Rocca G; Cardillo M; Trapanese C; Caradonna M; Licata G
    Clin Drug Investig; 2009; 29(9):591-600. PubMed ID: 19663521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L; Frithz G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Broadened indications for the use of selective β-adrenoblockers].
    Mamedov MN
    Kardiologiia; 2012; 52(5):74-6. PubMed ID: 22839590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
    Kayser A; Beck E; Hoeltzenbein M; Zinke S; Meister R; Weber-Schoendorfer C; Schaefer C
    J Hypertens; 2020 Feb; 38(2):354-361. PubMed ID: 31584512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension.
    Kanegae K; Hiroshige K; Suda T; Iwamoto M; Ohta T; Nakashima Y; Ohtani A
    Int J Artif Organs; 1999 Dec; 22(12):798-804. PubMed ID: 10654875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between the antihypertensive effects of bisoprolol and levels of plasma atrial natriuretic peptide in hypertensive patients.
    Baláti B; Phung H; Pousset F; Isnard R; Boisvieux A; Carayon A; Komajda M; Lechat P
    Fundam Clin Pharmacol; 2002 Oct; 16(5):361-8. PubMed ID: 12602461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations.
    Skoczylas A; Piecha G; Więcek A
    Pol Arch Med Wewn; 2016 Apr; 126(4):243-53. PubMed ID: 27129086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
    Vaïsse B; Herpin D; Asmar R; Battistella P; Zannad F; Boutelant S; Lyon A; Conte D; Denis J; Honore P; Contard S; Prost PL; Mallion JM; Poggi L
    J Cardiovasc Pharmacol; 1997 May; 29(5):612-7. PubMed ID: 9213203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three years of experience with bisoprolol in the treatment of mild to moderate hypertension.
    Giesecke HG; Buchner-Möll D
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S175-8. PubMed ID: 11527123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Jpn Circ J; 2001 Sep; 65(9):775-8. PubMed ID: 11548874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris].
    Burkart F; Stamm G; Witassek F
    Schweiz Med Wochenschr; 1989 May; 119(18):575-81. PubMed ID: 2568685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitrendipine in the therapeutic management of elderly hypertensive patients: results of a multicenter trial. Andalousian Hypertension Group.
    Aranda P; Lopez S; Fernandez JA; Lopez de Novales E
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S36-8. PubMed ID: 1377302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life.
    Bulpitt CJ; Connor M; Schulte M; Fletcher AE
    J Hum Hypertens; 2000 Mar; 14(3):205-12. PubMed ID: 10694836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
    Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
    Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.